rs397516433
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_000501.4(ELN):c.800-3C>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000501.4 splice_region, intron
Scores
Clinical Significance
Conservation
Publications
- cutis laxa, autosomal dominant 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, Genomics England PanelApp, G2P
- supravalvular aortic stenosisInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- autosomal dominant cutis laxaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial thoracic aortic aneurysm and aortic dissectionInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ELN | NM_000501.4 | c.800-3C>G | splice_region_variant, intron_variant | Intron 15 of 32 | ENST00000252034.12 | NP_000492.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ELN | ENST00000252034.12 | c.800-3C>G | splice_region_variant, intron_variant | Intron 15 of 32 | 1 | NM_000501.4 | ENSP00000252034.7 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Supravalvar aortic stenosis Pathogenic:4
This sequence change falls in intron 15 of the ELN gene. It does not directly change the encoded amino acid sequence of the ELN protein. It affects a nucleotide within the consensus splice site. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individuals with supravalvular aortic stenosis (PMID: 9215670, 10190324). It has also been observed to segregate with disease in related individuals. This variant is also known as IVS15-3C>G. ClinVar contains an entry for this variant (Variation ID: 43586). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.
The 800-3C>G variant has been reported in 3 families with SVAS and segregated wi th disease in >10 affected individuals (Li 1997, Urban 1999). The variant was no t detected in over 900 control chromosomes, supporting a pathogenic role (Li 199 7, Urban 1999). This variant is located in the 3' splice region and although it does not affect the highly conserved -1 and -2 positions, molecular studies show ed abnormal splicing and skipping of exon 16 (Urban 1999, Wachi 2007). In summar y, the 800-3C>G variant meets our criteria for pathogenicity (http://pcpgm.partn ers.org/lmm) based on the severity of the change, segregation with disease, func tional studies, and absence from controls.
The ELN c.800-3C>G variant (also known as IVS15-3C>G) has been observed in individuals with supravalvular aortic stenosis and segregates with disease (Li DY et al., PMID: 9215670; Urban Z et al., PMID: 10190324). Two different studies performed functional analysis on patient fibroblasts. Wachi and colleagues demonstrated that this variant causes skipping of exons 16-17 and results in stable mRNA (Wachi H et al., PMID: 17037986). They further concluded that tropolastin lacking these exons results in reduced self-association and altered elastic fiber formation. Conversely, Urban and colleagues showed generation of a cryptic splice that would lead to a frameshift and reduced expression, indicating haploinsufficiency (Urban Z et al., PMID: 10190324). This variant is absent from the general population (gnomAD v.4.1.0), indicating it is not a common variant. Computational predictors indicate that this variant would alter splicing, evidence that correlates to an impact of this variant on ELN function. This variant has been reported in the ClinVar database as a pathogenic variant by five submitters (ClinVar Variation ID: 43586). Based on available information and the ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), this variant is classified as pathogenic.
Inborn genetic diseases Pathogenic:1
The alteration results in an intronic change: _x000D_ _x000D_ The c.800-3C>G intronic alteration results from a C to G substitution 3 nucleotides before coding exon 16 of the ELN gene. The alteration is not observed in population databases:_x000D_ _x000D_ Based on data from the Genome Aggregation Database (gnomAD), the ELN c.800-3C>G alteration was not observed, with coverage at this position. The alteration has been observed in affected individuals: _x000D_ _x000D_ The ELN c.800-3C>G alteration (also referred to as IVIS15-3C>G) has been reported to segregate with supravalvular aortic stenosis in at least three unrelated families (Li, 1997; Urban, 1999). The altered nucleotide is conserved throughout evolution:_x000D_ _x000D_ The c.800-3C nucleotide is conserved in available vertebrate species. Molecular analysis reveals aberrant splicing from this alteration:_x000D_ _x000D_ Using mRNA studies, Urbán et al. (1999) and Wachi et al. (2007) demonstrated that c.800-3C>G alteration leads to aberrant splicing and exon skipping in the ELN gene. Additional studies by Wachi et al. (2007) showed that this aberrantly spliced transcript was able to synthesize a stable polypeptide that could interact with fibrillin-1 and fibulin-5 proteins, but was deficient in forming homotypic interactions. The alteration is predicted to affect splicing by in silico models:_x000D_ _x000D_ Based on BDGP and ESEfinder splice site in silico tools, this alteration is predicted to abolish the native splice acceptor site and is supported by molecular studies (see above). Based on the available evidence, this alteration is classified as pathogenic.
not provided Pathogenic:1
Non-canonical splice site variant predicted to destroy the natural splice acceptor site in intron 15; Published functional studies demonstrate the production of aberrant mRNA lacking exons 16 and 17 in skin fibroblasts of affected individuals (Wachi et al., 2007); Not observed in large population cohorts (gnomAD); In silico analysis supports a deleterious effect on splicing; This variant is associated with the following publications: (PMID: 11175284, 17037986, 10190324, 9215670)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at